首頁 > 市場調查報告書 > 醫療設備

體外診斷

早產和胎膜早破檢測市場規模、佔有率和成長分析：按產品類型、檢測類型、技術、應用、最終用戶、分銷管道和地區分類－2026-2033年產業預測

市場調查報告書

商品編碼

2054159

早產和胎膜早破檢測市場規模、佔有率和成長分析：按產品類型、檢測類型、技術、應用、最終用戶、分銷管道和地區分類－2026-2033年產業預測

Preterm Birth And PROM Testing Market Size, Share, and Growth Analysis, By Product Type, By Test Type, By Technology, By Application, By End User, By Distribution Channel, By Region - Industry Forecast 2026-2033

出版日期: 2026年05月27日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2024 年全球早產和胎膜早破 (PROM) 檢測市場價值為 18 億美元，預計到 2033 年將從 2025 年的 19.4 億美元成長到 34.5 億美元，預測期（2026-2033 年）的複合年成長率為 7.5%。

早產和胎膜早破 (PROM) 檢測市場的發展動力源於對早期發現羊膜破裂和早產的迫切需求，而這種需求又受到早產率上升、高齡產婦以及輔助生殖技術普及的影響。該市場涵蓋了產前和急診醫療中使用的各種診斷工具，例如照護現場(POC)橫向流動化驗、生物標記檢測和影像技術。向生物標記檢測和分子診斷的轉變能夠實現更快、更可靠的診斷，從而降低新生兒發病率和重症監護成本。快速診斷技術的創新提高了臨床效率，並減少了不必要的干涉。此外，人工智慧的進步透過促進複雜數據模式的分析、改進風險分層以及為臨床醫生提供及時支持，提高了診斷準確性。這些因素最終吸引了保險公司的關注，並推動了這些技術在醫療保健領域的更廣泛應用。

全球早產和胎膜早破檢測市場的成長要素

全球早產和胎膜早破（PROM）檢測市場的主要促進因素之一是全球早產發生率的不斷上升。孕婦年齡、生活方式和健康狀況等因素都會導致早產率上升，從而增加對有效診斷工具和檢測方案的需求。人們對早產併發症的認知不斷提高，促使醫護人員和孕婦尋求預防措施和早期療育，進而推動了先進診斷檢測的需求。此外，產前護理領域的持續研究和技術進步有望透過提供更準確可靠的檢測方案來促進市場成長。

全球早產和胎膜早破檢測市場的限制因素

全球早產和胎膜早破（PROM）篩檢市場的主要限制因素是先進診斷技術和治療的高成本。這些創新技術的經濟負擔可能成為許多醫療服務提供者和患者，特別是預算緊張的中低收入地區的患者，難以獲得這些服務。此外，某些檢測和治療缺乏保險報銷也可能阻礙醫療專業人員採用這些方案，進一步抑制市場成長。這些經濟因素，加上區域醫療基礎設施的差異，持續對早產和胎膜早破篩檢方案的廣泛應用構成挑戰。

早產和胎膜早破檢測的全球市場趨勢

全球早產和胎膜早破檢測市場正呈現即時診斷（POC）平台快速普及的顯著趨勢。這種檢測的快速分散化正在提升產前和急診醫療環境中的臨床決策水平，並簡化患者管理流程。醫療專業人員越來越傾向於使用便利的檢測方法，這些方法能夠無縫整合到現有工作流程中，並在診療過程中提供可操作的結果。因此，設備製造商和醫療服務提供者之間的合作日益密切，從而促進了本地診所的檢測服務普及。這一趨勢不僅有助於改善患者照護，還推動了對使用者培訓、品管和報銷模式的投入，從而加強了對早產風險和羊膜破裂的常規篩檢。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太國家
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲國家
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲國家

競爭資訊

前五大公司對比
主要公司2025年的市場定位
主要市場公司採取的策略
近期市場趨勢
企業市場占有率分析，2025 年
主要公司的完整公司簡介
- 公司詳情
- 產品系列分析
- 按細分市場進行企業市佔率分析
- 銷售收入年比比較（2023-2025 年）

主要公司簡介

Hologic
Qiagen
Abbott Laboratories
F. Hoffmann-La Roche
Thermo Fisher Scientific
PerkinElmer
Sera Prognostics
NX Prenatal
IQ Products
Biosynex
Clinical Innovations
CooperSurgical
Medix Biochemica
Laborie Medical Technologies
Sekisui Diagnostics
QuidelOrtho
bioMerieux
BD
Siemens Healthineers
Creative Diagnostics

結論與建議

簡介目錄

Product Code: SQMIG35A3538

Global Preterm Birth And Prom Testing Market size was valued at USD 1.8 Billion in 2024 and is poised to grow from USD 1.94 Billion in 2025 to USD 3.45 Billion by 2033, growing at a CAGR of 7.5% during the forecast period (2026-2033).

The preterm birth and PROM testing market is driven by the urgent need for early identification of membrane rupture and preterm labor, influenced by rising preterm rates, advancing maternal age, and increased assisted reproduction practices. This market encompasses various diagnostic tools, including point-of-care lateral flow assays, biomarker panels, and imaging techniques used in prenatal and emergency settings. The shift towards biomarker assays and molecular diagnostics has enabled faster, more reliable diagnoses, thus reducing neonatal morbidity and intensive care costs. Technological innovation in rapid diagnostics enhances clinical efficiency and reduces unnecessary interventions. Additionally, AI advancements are elevating diagnostic accuracy by analyzing complex data patterns, improving risk stratification, and fostering timely clinician support, ultimately driving payer interest and broader implementation in healthcare settings.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Preterm Birth And Prom Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Preterm Birth And Prom Testing Market Segments Analysis

Global preterm birth and prom testing market is segmented by product type, test type, technology, application, end user, distribution channel and region. Based on product type, the market is segmented into Biomarker Test Kits, Rapid Diagnostic Tests, Instruments & Analyzers and Consumables & Reagents. Based on test type, the market is segmented into PROM Tests, Fetal Fibronectin (fFN) Tests, PAMG-1 Tests, IGFBP-1 Tests and Others. Based on technology, the market is segmented into Immunoassay-Based Testing, Lateral Flow Assays, Molecular Diagnostics and Point-of-Care Testing. Based on application, the market is segmented into Preterm Labor Risk Assessment, Premature Rupture of Membranes Detection, Pregnancy Monitoring and Obstetric Emergency Assessment. Based on end user, the market is segmented into Hospitals, Maternity Clinics, Diagnostic Laboratories and Ambulatory Care Centers. Based on distribution channel, the market is segmented into Direct Sales, Distributors and Online Sales. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Preterm Birth And Prom Testing Market

One of the key market drivers for the global preterm birth and PROM (premature rupture of membranes) testing market is the increasing prevalence of preterm births worldwide. Factors such as maternal age, lifestyle choices, and health conditions contribute to the rising incidence of preterm deliveries, necessitating the need for effective diagnostic tools and testing solutions. Enhanced awareness about the complications associated with preterm births pushes healthcare providers and expectant mothers to seek preventive measures and early interventions, thus driving demand for advanced diagnostic tests. Furthermore, ongoing research and technological advancements in prenatal care are likely to bolster market growth by providing more accurate and reliable testing options.

Restraints in the Global Preterm Birth And Prom Testing Market

A significant market restraint in the Global Preterm Birth and PROM Testing Market is the high costs associated with advanced diagnostic technologies and treatments. The financial burden these innovations impose can limit accessibility for many healthcare providers and patients, particularly in low- and middle-income regions where budget constraints are prevalent. Additionally, the lack of reimbursement policies for certain tests and treatments may deter healthcare professionals from adopting these solutions, further stalling market growth. This economic factor coupled with the variability in healthcare infrastructure across different regions continues to pose a challenge to the widespread implementation of preterm birth and PROM screening solutions.

Market Trends of the Global Preterm Birth And Prom Testing Market

The Global Preterm Birth and PROM Testing market is witnessing a significant trend towards the adoption of point-of-care (POC) diagnostic platforms. This rapid decentralization of testing is enhancing clinical decision-making and streamlining patient management in prenatal and emergency settings. Healthcare providers are increasingly favoring user-friendly assays that seamlessly integrate into existing workflows to generate actionable results during consultations. Consequently, collaborations between device manufacturers and care providers are on the rise, promoting broader access in community clinics. This trend not only supports enhanced patient care but also drives investments in user training, quality control, and reimbursement models, reinforcing the routine screening for preterm birth risks and membrane rupture.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index 2025
PESTEL Analysis
Regulatory Landscape
Value Chain Analysis
Case Studies
Technology Assessment
Customer & Buying Criteria Analysis
Pipeline Analysis
Disease Epidemiology

Global Preterm Birth And PROM Testing Market Size by Product Type & CAGR (2026-2033)

Market Overview
Biomarker Test Kits
Rapid Diagnostic Tests
Instruments & Analyzers
Consumables & Reagents

Global Preterm Birth And PROM Testing Market Size by Test Type & CAGR (2026-2033)

Market Overview
PROM Tests
Fetal Fibronectin (fFN) Tests
PAMG-1 Tests
IGFBP-1 Tests
Others

Global Preterm Birth And PROM Testing Market Size by Technology & CAGR (2026-2033)

Market Overview
Immunoassay-Based Testing
Lateral Flow Assays
Molecular Diagnostics
Point-of-Care Testing

Global Preterm Birth And PROM Testing Market Size by Application & CAGR (2026-2033)

Market Overview
Preterm Labor Risk Assessment
Premature Rupture of Membranes Detection
Pregnancy Monitoring
Obstetric Emergency Assessment

Global Preterm Birth And PROM Testing Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals
Maternity Clinics
Diagnostic Laboratories
Ambulatory Care Centers

Global Preterm Birth And PROM Testing Market Size by Distribution Channel & CAGR (2026-2033)

Market Overview
Direct Sales
Distributors
Online Sales

Global Preterm Birth And PROM Testing Market Size & CAGR (2026-2033)

North America (Product Type, Test Type, Technology, Application, End User, Distribution Channel)
- US
- Canada
Europe (Product Type, Test Type, Technology, Application, End User, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Test Type, Technology, Application, End User, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Test Type, Technology, Application, End User, Distribution Channel)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Test Type, Technology, Application, End User, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Hologic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qiagen
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sera Prognostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NX Prenatal
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IQ Products
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biosynex
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Clinical Innovations
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CooperSurgical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medix Biochemica
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Laborie Medical Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sekisui Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QuidelOrtho
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMerieux
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BD
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Creative Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments